Published in Patient Care Law Weekly, April 5th, 2009
The first laboratory of its kind in the United States, PiRL, which is the result of a research collaboration between Phadia and National Jewish Health, will advance immunology by providing cutting-edge component-resolved diagnostics (CRD) at the molecular level with ImmunoCAP® Specific IgE blood test technology.
The sensitive measurement of very specific antibodies to antigenic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Patient Care Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.